The performance of different case definitions for severe influenza surveillance among HIV-infected and HIV-uninfected children aged <5 years in South Africa, 2011-2015.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 12 04 2019
accepted: 26 08 2019
entrez: 20 9 2019
pubmed: 20 9 2019
medline: 13 3 2020
Statut: epublish

Résumé

In 2014, the World Health Organization (WHO) proposed a new severe influenza surveillance case definition, which has not been evaluated in a high human immunodeficiency virus (HIV) prevalence setting. Our study aimed to assess the performance of this proposed case definition in identifying influenza among HIV-uninfected and HIV-infected children aged <5 years in South Africa. We prospectively enrolled children aged <5 years hospitalised with physician-diagnosed lower respiratory tract infection (LRTI) at two surveillance sites from January 2011 to December 2015. Epidemiologic and clinical data were collected. We tested nasopharyngeal aspirates for influenza using reverse transcription polymerase chain reaction. We used logistic regression to assess factors associated with influenza positivity among HIV-infected and HIV-uninfected children. We calculated sensitivity and specificity for different signs and symptoms and combinations of these for laboratory-confirmed influenza. We enrolled 2,582 children <5 years of age with LRTI of whom 87% (2,257) had influenza and HIV results, of these 14% (318) were HIV-infected. The influenza detection rate was 5% (104/1,939) in HIV-uninfected and 5% (16/318) in HIV-infected children. Children with measured fever (≥38°C) were two times more likely to test positive for influenza than those without measured fever among the HIV-uninfected (OR 2.2, 95% Confidence Interval (CI) 1.5-3.4; p<0.001). No significant association was observed between fever and influenza infection among HIV-infected children. Cough alone had sensitivity of 95% (95% CI 89-98%) in HIV-uninfected and of 100% (95% CI 79-100%) in HIV-infected children but low specificity: 7% (95% CI 6-8%) and 6% (95% CI 3-9%) in HIV-uninfected and HIV-infected children, respectively. The WHO post-2014 case definition for severe acute respiratory illness (SARI-an acute respiratory infection with history of fever or measured fever of ≥ 38°C and cough; with onset within the last ten days and requires hospitalization), had a sensitivity of 66% (95% CI 56-76%) and specificity of 46% (95% CI 44-48%) among HIV-uninfected and a sensitivity of 63% (95% CI 35-84%) and a specificity of 42% (95% CI 36-48%) among HIV-infected children. The sensitivity and specificity of the WHO post-2014 case definition for SARI were similar among HIV-uninfected and HIV-infected children. Our findings support the adoption of the 2014 WHO case definition for children aged <5 years irrespective of HIV infection status.

Identifiants

pubmed: 31536552
doi: 10.1371/journal.pone.0222294
pii: PONE-D-19-10479
pmc: PMC6752836
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0222294

Déclaration de conflit d'intérêts

The authors have read the journal's policy and have the following competing interests: Stefano Tempia is a paid employee of MassGenics. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Cytometry. 2002 Apr 15;50(2):69-77
pubmed: 12116348
Euro Surveill. 2017 Apr 6;22(14):
pubmed: 28422004
Influenza Other Respir Viruses. 2018 May;12(3):360-373
pubmed: 29210203
J Clin Virol. 2003 Jul;27(2):170-9
pubmed: 12829039
Influenza Other Respir Viruses. 2015 Aug;9 Suppl 1:23-9
pubmed: 26256292
South Afr J HIV Med. 2017 Jul 27;18(1):694
pubmed: 29568630
Emerg Infect Dis. 2014 Jul;20(7):1162-9
pubmed: 24960314
Bull World Health Organ. 2012 Nov 1;90(11):804-12
pubmed: 23226892
Clin Infect Dis. 2014 May;58(9):1241-9
pubmed: 24567249
Bull World Health Organ. 2018 Feb 1;96(2):122-128
pubmed: 29403115
Antimicrob Agents Chemother. 1983 Apr;23(4):577-82
pubmed: 6859836
J Infect Dis. 2012 Dec 15;206 Suppl 1:S159-65
pubmed: 23169964
J Pediatr. 2000 Jul;137(1):78-84
pubmed: 10891826
Influenza Other Respir Viruses. 2013 May;7(3):321-9
pubmed: 22804843

Auteurs

Hetani Ngobeni (H)

South African Field Epidemiology Training Programme, Johannesburg, South Africa.
School of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa.

Stefano Tempia (S)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Influenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa.
MassGenics, Duluth, Georgia, United States of America.

Adam L Cohen (AL)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Global Immunization Monitoring and Surveillance Team, Vaccines and Biologicals, World Health Organisation, Geneva, Switzerland.

Sibongile Walaza (S)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.

Lazarus Kuonza (L)

South African Field Epidemiology Training Programme, Johannesburg, South Africa.
School of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa.
School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

Alfred Musekiwa (A)

School of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa.

Anne von Gottberg (A)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Orienka Hellferscee (O)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.

Nicole Wolter (N)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Florette K Treurnicht (FK)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.

Jocelyn Moyes (J)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

Fathima Naby (F)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.

Omphile Mekgoe (O)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.

Cheryl Cohen (C)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH